Allan Jonathan Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$583,173.05

Insider Activity of Allan Jonathan

According to the SEC Form 4 filings, Allan Jonathan, being in a position of

  1. GENERAL COUNSEL & CORP SEC at Stoke Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 41490 shares for $1.32M,
    over all time since 2023-06-21, has bought 0 shares, and sold 134597 shares for $2.84M.

Biography of Allan Jonathan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,323,72611100

Comparison of Insiders on Amount of Buys and Sells

2026-10-02SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
627
0.001%
$26.33$16,509-1.72%
2026-08-18SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
2,861
0.0044%
$32.03$91,639-17.72%
2026-06-16SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
1,457
0.0024%
$29.95$43,637+1.06%
2026-03-20SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
9,293
0.0158%
$33.69$313,038-9.28%
2026-03-18SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
4,628
0.0082%
$31.34$145,063-1.77%
2026-03-17SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
4,267
0.0075%
$33.01$140,838-7.26%
2025-12-08SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
3,978
0.0068%
$32.28$128,411-4.85%
2025-12-05SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
8,785
0.0156%
$31.29$274,898+1.8%
2025-12-04SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
1,018
0.0018%
$30.87$31,425+1.13%
2025-12-03SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
2,292
0.004%
$30.65$70,245+1.39%
2025-12-02SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
2,284
0.004%
$29.78$68,023+5.27%
2025-10-03SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
10,000
0.0195%
$25.07$250,650+23.36%
2025-09-03SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
6,345
0.0118%
$20.07$127,317+58.98%
2025-09-02SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
14,922
0.028%
$20.14$300,492+60.44%
2025-08-29SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
850
0.0016%
$20.00$17,000+59.56%
2025-08-18SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
1,683
0.003%
$18.24$30,695+68.07%
2025-08-13SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
13,712
0.0223%
$15.00$205,680+83.62%
2025-03-19SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
1,945
0.0037%
$8.27$16,085+176.63%
2025-03-18SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
2,266
0.0042%
$8.67$19,646+157.27%
2024-12-09SaleStoke Therapeutics, Inc.
STOK
GENERAL COUNSEL & CORP SEC
13,666
0.0256%
$13.61$185,978-15.3%
Total: 25
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.